drugset / Trial / NCT00535860
Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the clinical efficacy, safety, and tolerability of ViaDerm-shPTH \[1-34\] transdermal delivery in comparison to subcutaneous injection of rhPTH\[1-34\] following 3-month treatment in postmenopausal women with Osteoporosis
Timeline
- Start
- 2008-04
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teriparatide | Protein / enzyme biologic | 20 ug | Other |
| Subject | Teriparatide | Protein / enzyme biologic | 50 ug | Other |
| Subject | Teriparatide | Protein / enzyme biologic | 80 ug | Other |